Skip to main content
ALVO
NASDAQ Life Sciences

Entities tied to Alvotech CEO and Board acquire $59.5M in shares

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
9
Price
$4.62
Mkt Cap
$1.349B
52W Low
$4.32
52W High
$13.7
Market data snapshot near publication time

summarizeSummary

Entities closely associated with Alvotech's CEO and Board members collectively acquired approximately $59.5 million worth of shares in December 2025, signaling strong insider confidence.


check_boxKey Events

  • Significant Insider Purchases

    Two entities, Alvogen Lux Holdings S.a. r.l. and ATP Holdings ehf., collectively acquired approximately $59.5 million in Alvotech shares.

  • Closely Associated Persons

    These acquiring entities are closely associated with Alvotech's CEO and Chairman, Róbert Wessman, and other board members Tomas Ekman and Arni Hardarson.

  • Transaction Details

    The shares were acquired at SEK 44.06 per share across multiple transactions on December 17 and December 19, 2025.


auto_awesomeAnalysis

This 6-K filing reports substantial insider buying by entities linked to Alvotech's top leadership. The collective acquisition of approximately $59.5 million in shares represents a significant vote of confidence from those with the deepest understanding of the company's operations and future prospects. Such a large-scale purchase, especially by entities associated with the CEO and Chairman, often signals that insiders believe the stock is undervalued or that positive developments are anticipated. Investors should view this as a strong positive indicator, suggesting potential upside.

At the time of this filing, ALVO was trading at $4.62 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $4.32 to $13.70. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed ALVO - Latest Insights

ALVO
Mar 30, 2026, 7:28 PM EDT
Filing Type: 20-F
Importance Score:
8
ALVO
Mar 18, 2026, 6:15 PM EDT
Source: GlobeNewswire
Importance Score:
8
ALVO
Mar 12, 2026, 4:09 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
ALVO
Feb 05, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
8
ALVO
Feb 02, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
7
ALVO
Jan 29, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
9
ALVO
Jan 07, 2026, 5:30 PM EST
Filing Type: 6-K
Importance Score:
9
ALVO
Jan 07, 2026, 11:00 AM EST
Filing Type: 6-K
Importance Score:
9
ALVO
Jan 06, 2026, 1:08 PM EST
Filing Type: 6-K
Importance Score:
7
ALVO
Jan 02, 2026, 11:16 AM EST
Filing Type: 6-K
Importance Score:
8